{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T05:26:09Z","timestamp":1791437169354,"version":"4.3.3"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100016226","name":"Accuray","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016226","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.radonc.2019.11.009","type":"journal-article","created":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T07:41:34Z","timestamp":1590046894000},"page":"163-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Percussion assisted radiation therapy in Hodgkin lymphoma allows a marked reduction in heart dose"],"prefix":"10.1016","volume":"152","author":[{"given":"Andr\u00e9-Dante","family":"Durham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alban","family":"Lovis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flore","family":"Buela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Ogna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Jumeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Cairoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Rocha Do Carmo Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Zeverino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Patin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Vallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5885-934X","authenticated-orcid":false,"given":"Rapha\u00ebl","family":"Moeckli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5162-1171","authenticated-orcid":false,"given":"Jean","family":"Bourhis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmut","family":"Ozsahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2019.11.009_b0005","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1200\/JCO.2005.05.2746","article-title":"Combined-modality therapy for clinical stage I or II Hodgkin\u2019s lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials","volume":"24","author":"Noordijk","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2019.11.009_b0010","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1200\/JCO.2016.70.9410","article-title":"Long-term follow-up of contemporary treatment in early-stage Hodgkin lymphoma: updated analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials","volume":"35","author":"Sasse","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2019.11.009_b0015","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1056\/NEJMoa064601","article-title":"Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease","volume":"357","author":"Ferme","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2019.11.009_b0020","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1200\/JCO.2003.07.131","article-title":"Long-term cause-specific mortality of patients treated for Hodgkin's disease","volume":"21","author":"Aleman","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2019.11.009_b0025","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2019.11.009_b0030","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1200\/JCO.2015.63.4444","article-title":"Radiation dose-response relationship for risk of coronary heart disease in survivors of Hodgkin lymphoma","volume":"34","author":"van Nimwegen","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2019.11.009_b0035","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijrobp.2010.09.007","article-title":"Involved-node radiotherapy and modern radiation treatment techniques in patients with Hodgkin lymphoma","volume":"80","author":"Paumier","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.11.009_b0040","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1164\/rccm.201608-1572LE","article-title":"Prolonged apnea supported by high-frequency noninvasive ventilation: a pilot study","volume":"195","author":"Ogna","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.radonc.2019.11.009_b0045","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.radonc.2015.10.011","article-title":"Apnea-like suppression of respiratory motion: First evaluation in radiotherapy","volume":"118","author":"Peguret","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.11.009_b0050","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.radonc.2006.05.015","article-title":"Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines","volume":"79","author":"Girinsky","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.11.009_b0055","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2967\/jnumed.115.163386","article-title":"Reduction of respiratory motion during PET\/CT by pulsatile-flow ventilation: a first clinical evaluation","volume":"57","author":"Prior","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.radonc.2019.11.009_b0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178807","article-title":"Chest-MRI under pulsatile flow ventilation: a new promising technique","volume":"12","author":"Beigelman-Aubry","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.radonc.2019.11.009_b0065","doi-asserted-by":"crossref","DOI":"10.1007\/s40273-019-00795-4","article-title":"A systematic review of direct cardiovascular event costs: an international perspective","author":"Ryder","year":"2019","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.radonc.2019.11.009_b0070","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.ijrobp.2011.05.015","article-title":"Dosimetric benefits of intensity-modulated radiotherapy combined with the deep-inspiration breath-hold technique in patients with mediastinal Hodgkin's lymphoma","volume":"82","author":"Paumier","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.11.009_b0075","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/0284186X.2014.932435","article-title":"Prospective phase II trial of image-guided radiotherapy in Hodgkin lymphoma: benefit of deep inspiration breath-hold","volume":"54","author":"Petersen","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2019.11.009_b0080","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s00066-011-0044-5","article-title":"RapidArc combined with the active breathing coordinator provides an effective and accurate approach for the radiotherapy of hepatocellular carcinoma","volume":"188","author":"Gong","year":"2012","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2019.11.009_b0085","doi-asserted-by":"crossref","first-page":"e667","DOI":"10.1016\/j.ijrobp.2011.01.061","article-title":"Dosimetric comparison of involved-field three-dimensional conformal photon radiotherapy and breast-sparing proton therapy for the treatment of Hodgkin's lymphoma in female pediatric patients","volume":"81","author":"Andolino","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.11.009_b0090","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.ijrobp.2008.12.048","article-title":"Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin\u2019s lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy","volume":"75","author":"Chera","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.11.009_b0095","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijrobp.2010.05.007","article-title":"Rationale for and preliminary results of proton beam therapy for mediastinal lymphoma","volume":"81","author":"Li","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.11.009_b0100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.radonc.2017.07.033","article-title":"Life years lost attributable to late effects after radiotherapy for early stage Hodgkin lymphoma: the impact of proton therapy and\/or deep inspiration breath hold","volume":"125","author":"Rechner","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.11.009_b0105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/153303460600500102","article-title":"Technical note: gold marker implants and high-frequency jet ventilation for stereotactic, single-dose irradiation of liver tumors","volume":"5","author":"Fritz","year":"2006","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.radonc.2019.11.009_b0110","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijrobp.2009.07.1678","article-title":"High-frequency jet ventilation for complete target immobilization and reduction of planning target volume in stereotactic high single-dose irradiation of stage I non-small cell lung cancer and lung metastases","volume":"78","author":"Fritz","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.11.009_b0115","first-page":"6(1)","article-title":"Extra-Corporeal Membrane Oxygenation for Arrested Lung Ablative Radiation","author":"Montilla","year":"2015","journal-title":"Therapy. J Anesth Clin Res"},{"key":"10.1016\/j.radonc.2019.11.009_b0120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.radonc.2013.09.013","article-title":"Reproducibility of target coverage in stereotactic spot scanning proton lung irradiation under high frequency jet ventilation","volume":"109","author":"Santiago","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.11.009_b0125","doi-asserted-by":"crossref","first-page":"20160194","DOI":"10.1259\/bjr.20160194","article-title":"Safely prolonging single breath-holds to >5 min in patients with cancer; feasibility and applications for radiotherapy","volume":"89","author":"Parkes","year":"2016","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2019.11.009_b0130","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.ijrobp.2018.11.040","article-title":"Mitigating respiratory motion in radiation therapy: rapid, shallow, non-invasive mechanical ventilation for internal thoracic targets","volume":"103","author":"West","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.11.009_b0135","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1667\/RR14213.1","article-title":"Thyroid cancer after childhood exposure to external radiation: an updated pooled analysis of 12 studies","volume":"185","author":"Veiga","year":"2016","journal-title":"Radiat Res"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814019334759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814019334759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:14:00Z","timestamp":1759122840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814019334759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":27,"alternative-id":["S0167814019334759"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2019.11.009","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Percussion assisted radiation therapy in Hodgkin lymphoma allows a marked reduction in heart dose","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2019.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}